4-hydroxyphenylpyruvate dioxygenase inhibitor therapy

[pnrobinson]

@LCCarmody
We need this for the Tyrosinaemia type I example
see - https://pubmed.ncbi.nlm.nih.gov/9728331/ and other OMIM entries

suggested def

Treatment with any member of a group of drugs that reduce the activity of 4-hydroxyphenylpyruvate dioxygenase. An example is NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).
Comment: In patients with tyrosinemia, treatment with NTBC has been shown to efficiently prevent tyrosine degradation, and production of succinylacetone.PMID: 9728331

[LCCarmody]

I"ve already added it. MAXO:0001501, but it isn't out yet because I need to (have Nico) make a release

[LCCarmody]

already added, but switched labels for ease of finding.